Streptokinaza u komplikovanoj pleuralnoj efuziji u dece

Boris Kovacevic ,
Boris Kovacevic
Milka Micic-Stanojevic
Milka Micic-Stanojevic

Published: 01.12.2010.

Biochemistry

Volume 27, Issue 1 (2011)

pp. 232-236;

https://doi.org/10.5937/matmed1101232k

Abstract

U pedijatrijskoj praksi poslednjih godina uočena je povećana učestalost pleuralnih efuzija. Prema načinu nastanka pleuralne efuzije su podeljene na eksudate i transudate. U grupi eksudata najčešće se sreću parapneumonične efuzije i empijem. Parapneumonična efuzija kod dece definiše se obično kao nakupljanje pleuralne tečnosti u toku akutne bakterijske pneumonije, a ređe u sklopu virusne pneumonije i tuberkuloznog pleuritisa. Empijem označava prisustvo purulentnog sadržaja u pleuralnom prostoru. Glavni bakterijski uzročnik pneumonija udruženih s izlivom je Streptococcus pneumoniae serotip 1. Kod 10% bolesnika ne dolazi do povlačenja pleuralne efuzije i pored konzervativnog lečenja. Tada sprovodimo standardizovan postupak prema smernicama BTS vodiča, sa algoritmom dijagnostičko-terapijskih mera. Signifikantna količina pleuralne tečnosti koja perzistira i kompromituje plućnu funkciju čini komplikovanu pleuralnu efuziju i indikovana je torakalna drenaža. Pri pojavi septacija i lokulacija u pleuralnom prostoru, neophodna je intrapleuralna instilacija fibrinolitika. Primena Streptokinaze je bezbedna, efikasna, smanjuje potrebu za hirurškim lečenjem i zajedno sa ostalim terapijskim merama dovodi do kompletnog oporavka deteta. Rana video-asistirana torakoskopija u kombinaciji sa fibrinoliticima verovatno će u budućnosti biti metoda izbora.

Keywords

References

1.
Balfour-Lynn I, Cohen E, G, Hartley, Parikh K. BTs guidelines for the management of pleural infection in children. Thorax. 2005;1–21.
2.
Masood I, Bhargava Z, Ahmad. role of Intrapleural streptokinase in Empyema. journal, Indian academy of Clinical Medicine. (4).
3.
Eastham K, Eltringham F, G, Leeming C.
4.
Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;522–5.
5.
Maskell N, Davies C, Nunn, Hedley E, Gleeson F, Miller R. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl j Med. 2005;865–74.
6.
Tokuda Y, Matsushima D, Stein G, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions; a metaanalysis. Chest. 2006;783–90.
7.
Uyan Ap, Ozyurek H, Yilmaz E. Using of fibrinolytics in the treatment of complicated parapneumonic effusions and empyema in children. Tuberk Toraks. 2003;320–4.
8.
Ms B. Intrapleural streptokinase in complicated parapneumonic effusions and empyema. IjCd. 2004;257–61.
9.
Demosthenes B. Intrapleural streptokinase for pleural infection. BMj. 2006;133–4.
10.
Yao C, Wu Jm, Liu C, Wu M, Chuang H, Jn W. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest. 2004;566–71.
11.
Luh Sp, Chou M, Ls W, Jy C, Tsai T. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest. 2005;1427–32.
12.
Nelson B. Textbook of Pediatrics. 18th ed. Philadelphia: saunders Company. 2007;3772600.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners